Photodynamic therapy: Palliation and endoscopic technique in cholangiocellular carcinoma

Frontiers of Gastrointestinal Research

Volumn 27, Issue , 2010, Pages 423-429

  Ibrahim, Tommy ^a   Kahaleh, Michel ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT;

BILE DUCT CARCINOMA; BILIARY TRACT ENDOSCOPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHOLANGITIS; CHOLESTASIS; CLINICAL TRIAL; DIGESTIVE TRACT ENDOSCOPY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; JAUNDICE; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STENT; TREATMENT OUTCOME;

EID: 77949396803     PISSN: 03020665     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000258385     Document Type: Review

References (45)

1. Callery MR, Meyers WC: Bile duct cancer; in Cameron JL (ed): Current Surgical Therapy, ed 6. Baltimore, Mosby, 1998, p 455.
2. Shahib Y, El-Serag HB: The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-125.
3. Burgos San Juan L: Cholangiocarcinoma (in Spanish). Rev Med Chil 2008;136:240-248.
4. Rubel LR, Ishak KG: Thorotrast-associated cholangiocarcinoma. Cancer 1982;50:1408-1415.
5. de Groen PC, Gores GJ, LaRusso NF, et al: Biliary tract cancers. N Engl J Med 1999;341:1368-1378.
6. Jarnagin WR, Fong Y, DeMatteo RP, et al: Staging respectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-519.
7. Reed DN Jr, Vitale GC, Martin R, et al: Bile duct carcinoma: trends in treatment in the nineties. Am Surg 2000;66:711-715.
8. Liu CL, Lo CM,Lai EC, et al: Endoscopic retrograde cholangio- pancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg 1998;133:293-296.
9. Polydorou AA, Cairns SR, Dowsett JF, et al: Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 1991; 32:685-689.
10. Ducreux M, Liguory C, Lefebvre JF, et al: Management of malignant hilar biliary obstruction by endoscopy: results and prognostic factors. Dig Dis Sci 1992;37:778-783.
11. Farley DR, Weaver AL, Nagorney DM. 'Natural history' of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995;70:425-429.
12. Baer HU, Stain SC, Dennison AR, et al: Improve ments in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 1993;217:20-27.
13. Deviere J, Baize M, de Toeuf J, et al: Long-term followup of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 1988;34:95-101.
14. Gibson RN, Yeung E, Hadjis N, et al: Percutaneous transhepatic endoprosthesis for hilar cholangiocarcinoma. Am J Surg 1988;156:363-367.
15. Lai EC, Tompkins RK, Mann LL, et al: Proximal bile duct cancer: quality of survival. Ann Surg 1987;205: 111-118.
16. Havlik R, Sbisa E, Tullo A, et al: Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. Hepatogastroenterology 2000;47:927-931.
17. Kapoor VK, Pradeep R, Haribhakti SP, et al: Intrahepatic segment III cholangiojejunostomy in advanced carcinoma of the gallbladder. Br J Surg 1996;83:1709-1711.
18. Chaudhary A, Dhar P, Tomey S, et al: Segment III cholangiojejunostomy for carcinoma of the gallbladder. World J Surg 1997;21:866-871.
19. Guthrie CM, Banting SW, Garden OJ, et al: Segment III cholangiojejunostomy for palliation of malignant hilar obstruction. Br J Surg 1994;81:1639-1641.
20. Figueras J, Llado L, Valls C, et al: Changing strategies in diagnosis and management of hilar cholangiocarcinoma Liver Transpl 2000;6:786-794.
21. Blom D, Schwartz SI: Surgical treatment and outcome in carcinoma of the extrahepatic bile ducts: the University of Rochester experience. Arch Surg 2001;136:209-215.
22. Smith AC, Dowse JF, Russell RC, Hatfield AR, Cotton PB: Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994;344:1655-1660.
23. Davids PH, Groen AK, Rauws EA, Tytgat GN, Hui bregtse K: Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;34:1488-1492.
24. Schmassmann A, von-Gunten E, Knuchel J, Scheurer U, Fehr HF, Halter F: Wall stents versus plastic stents in malignant biliary obstruction: effect of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 1996;91:654-659.
25. Born P, Rosch T, Bruhl K, Sandschin W, Weigert N, Ott R, et al: Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage. Z Gas troenterol 2000;38:483-489.
26. Peters RA, Williams SG, Lombard M, Karani J, Westaby D: The management of high grade hilar strictures by endoscopic insertion of self-expanding metal prostheses. Endoscopy 1997;29:10-16.
27. Prat F, Chapat O, Ducot B, Ponchon T, et al: A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998;42:76-80.
28. Van Groeningen CJ: Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer. Ann Oncol 1999;10:305-307.
29. Bowling TE, Galbraith SM, Hatfield AR, et al: A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996;39:852-855.
30. Baisden JM, Kahaleh M, Weiss GR, Sanfey H, Moskaluk CA, Yeaton P, de Lange EE, Rich TA: Multimodality treatment with helical tomotherapy intensity modulated radiotherapy, capecitabine, and photodynamic therapy is feasible and well tolerated in patients with hilar cholangiocarcinoma. Gastro intest Cancer Res 2008;2:219-224.
31. Ortner ME, Caca K, Berr F, et al: Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003;125:1355-1363.
32. Giuliano EA, Ota J, Tucker SA: Photodynamic therapy: basic principles and potential uses for the veterinary ophthalmologist. Vet Ophthalmol 2007;10: 337-343.
33. Henderson B, Waldow S, Mang T, et al: Tumor destruction and kinetics of cell death in tow experimental mouse tumors following photodynamic therapy. Cancer Res 1985;45:572-576.
34. Wong Kee Song LM, Wang KK, Zinsmeister AR: Mono- L-aspartyl chlorine e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer 1998;82:421-427.
35. Zoepf T, Jakobs R, Arnold JC, et al: Palliation of nonresectablebile duct cancer: Improved survival after photodynamic therapy. Am J Gastroenterol 2005;100:2426-2430.
36. Kahaleh M, Mishra R, Shami V, et al: Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol 2008;6: 290-297.
37. Talreja JP, Sauer B, Ellen K, Rehan ME, Shami VM, Kahaleh M: Photodynamic therapy for unresectable cholangiocarcinoma: what is the contribution of single operator cholangioscopy for targeted Treatment? Gastrointest Endosc 2009;69:AB146.
38. Vauthey JN, Blumgart LH: Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994; 14:109-114.
39. Prasad G, Wang K, Baron TH, et al: Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol 2007;5:743-748.
40. Ortner MA, Liebetruth J, Schreiber S, et al: Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998;114:536-542.
41. Berr F, Weidmann M, Taanapfel A, et al: Photo dynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000;31:291-298.
42. Rumalla A, Baron TH, Wang KK, et al: Endoscopic application of photodynamic therapy cholangiocarcinoma. Gastrointest Endosc 2001;53:500-504.
43. Dumoulin FL, Gerhardt T, Fuchs S, et al: Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 2003;57:860-867.
44. Harewood GC, Baron TH, Rumalla A, et al: Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol 2005;20: 415-420.
45. Witzigmann H, Berr F, Ringel U, et al: Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 2006;244:230.